Infusion Systems Clinical Trial Analysis

Summary

Global Markets Direct's "Infusion Systems Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Infusion Systems manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

• The report provides analysis and review of the key clinical trials being carried out globally and across key Infusion Systems market categories - Infusion Pumps,Syringe Pumps,Infusion Disposable Sets
• The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
• The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

• Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
• Stay ahead of the information curve in the fast changing Infusion Systems market.
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

• 1 List of Tables
• 1.2 List of Figures
• 2 Infusion Systems Clinical Trials
  • 2.1 Infusion Systems Clinical Trial By Equipment Type
  • 2.2 Infusion Systems Clinical Trials By Trial Phase and Trial Status
  • 2.3 Infusion Systems Pipeline Products By Development Stage
  • 2.4 Infusion Systems Pipeline Products By Therapy Area
  • 2.5 Infusion Systems Pipeline Products By News Summary
  • 2.6 Infusion Systems Helical Infusion Catheter
    • 2.6.1 Autologous Bone Marrow Transplanted Via Transendocardial Catheter To Chronic Myocardial Infarct Border Zone
    • 2.6.2 A Phase I/II, Randomized, Double-Blinded, Placebo-Controlled Study Of The Safety And Efficacy Of Transendocardial Injection Of Autologous Human Cells (Bone Marrow or Mesenchymal) In Patients With Chronic Ischemic Left Ventricular Dysfunction And Heart Failure Secondary To Myocardial Infarction
  • 2.7 Infusion Systems VeinRx Infusion catheter
    • 2.7.1 Abbreviated Method Of Determining Vein Volume In Balloon-Controlled Vein Ablation
• 3 Recent Developments
  • 3.1 Product News
    • 3.1.1 Jun 17, 2009: St. Jude Medical's Cool Point Irrigation Pump Receives FDA Approval
    • 3.1.2 Jan 08, 2009: Medegen Announces 510(k) Clearance For MaxGuard Advanced Luer-Activated Device With Antimicrobial Technology
    • 3.1.3 Dec 04, 2008: FlowMedica Receives FDA Clearance For New Indication For The Benephit Infusion Systems
    • 3.1.4 Nov 23, 2008: Thirty-Seven Patients Treated With Ultrasound Accelerated Catheter Direct Pharmacological Thrombolysis
    • 3.1.5 Nov 20, 2008: Trellis Peripheral Infusion System Removes Blood Clots In Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
    • 3.1.6 Sep 29, 2008: Baxter's Antimicrobial IV Technology Shown To Kill Six Common Pathogens, Including MRSA And VRE
    • 3.1.7 Aug 05, 2008: Pyng Medical Enhances Distribution Network And Secures German Military Order
    • 3.1.8 May 01, 2008: Pyng Medical Corp Receives FDA And Health Canada Clearance For Expanded Use Of FAST1
    • 3.1.9 Feb 25, 2008: Outlook Safety Infusion System Receives "Best in KLAS" In 2007 Top 20 Year-End Report
    • 3.1.10 Feb 19, 2008: Pyng Medical Receives US FDA Clearance For FAST1 Intraosseous Infusion System
    • 3.1.11 Nov 09, 2007: Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
    • 3.1.12 Sep 25, 2007: Angel Medical Center Advances Patient Safety, Treatment Efficiency With New Technology From B. Braun
    • 3.1.13 May 22, 2007: Study Results Indicate Smart Pump Technology Combined With Evidence-Based Protocols Reduce Infusion-Related Medication Events
    • 3.1.14 Mar 28, 2005: Bacchus Vascular Announces The US Clearance For The TRELLIS-8 Isolated Thrombolysis Catheter
  • 3.2 Product Approvals
    • 3.2.1 Jun 17, 2009: St. Jude Medical's Cool Point Irrigation Pump Receives FDA Approval
    • 3.2.2 Jan 08, 2009: Medegen Announces 510(k) Clearance For MaxGuard Advanced Luer-Activated Device With Antimicrobial Technology
    • 3.2.3 Dec 04, 2008: FlowMedica Receives FDA Clearance For New Indication For The Benephit Infusion Systems
  • 3.3 Clinical Trials
    • 3.3.1 Nov 23, 2008: Thirty-Seven Patients Treated With Ultrasound Accelerated Catheter Direct Pharmacological Thrombolysis
    • 3.3.2 Nov 20, 2008: Trellis Peripheral Infusion System Removes Blood Clots In Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
• 4 Appendix
  • 4.1 Methodology
    • 4.1.1 Coverage
    • 4.1.2 Secondary Research
    • 4.1.3 Primary Research
    • 4.1.4 Expert Panel Validation
  • 4.2 Contact Us
  • 4.3 About Global Markets Direct
  • 4.4 Disclaimer
• 1 List of Tables
  • Table 1: Infusion Systems Clinical Trial By Equipment Type
  • Table 2: Infusion Systems Clinical Trials By Trial Phase and Trial Status
  • Table 3: Infusion Systems Pipeline Products By Development Stage
  • Table 4: Infusion Systems Pipeline Products By Therapy Area
  • Table 5: Infusion Systems Pipeline Products By News Summary
  • Table 6: Helical Infusion Catheter - Autologous Bone Marrow Transplanted Via Transendocardial Catheter To Chronic Myocardial Infarct Border Zone
  • Table 7: Helical Infusion Catheter - A Phase I/II, Randomized, Double-Blinded, Placebo-Controlled Study Of The Safety And Efficacy Of Transendocardial Injection Of Autologous Human Cells (Bone Marrow or Mesenchymal) In Patients With Chronic Ischemic Left Ventricular Dysfunction And Heart Failure Secondary To Myocardial Infarction
  • Table 8: VeinRx Infusion catheter - Abbreviated Method Of Determining Vein Volume In Balloon-Controlled Vein Ablation
• 1.2 List of Figures
  • Figure 1: Global Markets Direct Methodology